Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Molecules (Basel, Switzerland)|March 18, 2020
Human Copper-Containing Amine Oxidases in Drug Design and DevelopmentSerhii Vakal, Sirpa Jalkanen, Käthe M Dahlström, et al.International Review of Neurobiology|September 23, 2023
A2AR antagonist treatment for multiple sclerosis: Current progress and future prospectsChenxing Qi, Yijia Feng, Yiwei Jiang, et al.The Journal of Pharmacology and Experimental Therapeutics|June 10, 2022
Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat AdministrationThomas Boehm, Marion Alix, Karin Petroczi, et al.Small (Weinheim an Der Bergstrasse, Germany)|January 27, 2022
A Rapid Corneal Healing Microneedle for Efficient Ocular Drug DeliveryHui Shi, Jianhong Zhou, Yuan Wang, et al.Frontiers in Molecular Biosciences|August 8, 2022
Advances in UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) Covalent InhibitionMaycon Vinicius Damasceno de Oliveira, Renan Machado Furtado, Kauê S da Costa, et al.RSC Advances|July 25, 2022
Virtual screening of natural products against 5-enolpyruvylshikimate-3-phosphate synthase using the Anagreen herbicide-like natural compound libraryMaycon Vinicius Damasceno de Oliveira, Gilson Mateus Bittencourt Fernandes, Kauê S da Costa, et al.Biochemical Pharmacology|June 23, 2020
A combination of inhibiting microglia activity and remodeling gut microenvironment suppresses the development and progression of experimental autoimmune uveitisJianhong Zhou, Jingjing Yang, Mali Dai, et al.Bioactive Materials|December 13, 2021
Drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interactionLin Chen, Jie Deng, Ailing Yu, et al.Biochemical Pharmacology|January 18, 2022
Ganciclovir attenuates the onset and progression of experimental autoimmune uveitis by inhibiting infiltration of Th17 and inflammatory cells into the retinaJianhong Zhou, Xiangxiang Lin, Huiping Shang, et al.Purinergic Signalling|February 15, 2022
Adenosine A2A receptor controls the gateway of the choroid plexusMengqian Ye, Mengru Wang, Yijia Feng, et al.Pageof 2